LINKING HAPLOTYPES AND GENETIC VARIATION WITH CANCER RISK ASSESSMENT, PREVENTION, DETECTION AND TREATMENT WORKSHOP
Workshop Dates:
December 4 - 5, 2003
Conference Site:
Bethesda Marriott Hotel
5151 Pooks Hill Road
Bethesda, MD 20814
(301) 897-9400
Goals:
- To review the status of the human haplotype map and haplotype analysis with relevance to cancer
- To assess the current status and needs of SNPs and haplotype research in human populations
- To recommend the future directions of application of haplotypes and genetic variation for studying cancer prevention, risk assessment, early detection, and treatment
Cosponsored by:
- National Cancer Institute (NCI)
- Division of Cancer Prevention (DCP)
- Division of Cancer Treatment and Diagnosis (DCTD)
- Division of Cancer Control and Population Sciences (DCCPS)
- National Human Genome Research Institute (NHGRI)